Most cited papers from Minerva Foundation

Minerva Foundation

What are the most cited papers from Minerva Foundation?

The most cited paper from Minerva Foundation is "Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes" (Siddhartha Jaiswal et al., 2014), with 4,900 citations. Next come "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement" (4,540) and "Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome" (1,293).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 248 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes Siddhartha Jaiswal et al. · New England Journal of Medicine Open access	26 Nov 2014	4,900
2	A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement Mohammed Eslam et al. · Journal of Hepatology Open access	8 Apr 2020	4,540
3	Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome Hannele Yki‐Järvinen · The Lancet Diabetes & Endocrinology	7 Apr 2014	1,293
4	The genetic architecture of type 2 diabetes Christian Fuchsberger et al. · Nature Open access301 authors	11 Jul 2016	1,129
5	The power of genetic diversity in genome-wide association studies of lipids Sarah E. Graham et al. · Nature Open access527 authors	9 Dec 2021	1,099
6	A saturated map of common genetic variants associated with human height Loïc Yengo et al. · Nature Open access632 authors	12 Oct 2022	934
7	Why does obesity cause diabetes? Samuel Klein, Amalia Gastaldelli, Hannele Yki‐Järvinen et al. · Cell Metabolism Open access	2022	934
8	The trans-ancestral genomic architecture of glycemic traits Jihua Chen et al. · Nature Genetics Open access417 authors	31 May 2021	918
9	ER stress and neurodegenerative diseases Dan Lindholm, Hanna Wootz, Laura Korhonen · Cell Death and Differentiation	6 Jan 2006	910
10	An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans Robert A. Scott et al. · Diabetes Open access175 authors	31 May 2017	830
11	Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors Anna Kotronen, Markku Peltonen, Antti Hakkarainen et al. · Gastroenterology Open access	13 Jun 2009	818
12	Fatty Liver Anna Kotronen, Hannele Yki‐Järvinen · Arteriosclerosis Thrombosis and Vascular Biology	10 Aug 2007	803
13	Advancing the global public health agenda for NAFLD: a consensus statement Jeffrey Victor Lazarus et al. · Nature Reviews Gastroenterology & Hepatology ReviewOpen access221 authors	27 Oct 2021	768
14	The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study Thomas W. Winkler et al. · PLoS Genetics Open access439 authors	Oct 2015	699
15	Exome-wide association study of plasma lipids in >300,000 individuals Charge Diabetes Working Group et al. · Nature Genetics Open access229 authors	30 Oct 2017	599
16	Effects of Rosiglitazone and Metformin on Liver Fat Content, Hepatic Insulin Resistance, Insulin Clearance, and Gene Expression in Adipose Tissue in Patients With Type 2 Diabetes Mirja Tiikkainen, Anna‐Maija Häkkinen, Elena Korsheninnikova et al. · Diabetes Open access	Aug 2004	528
17	Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism Sabine D. Jordan, Markus Krüger, Diana M. Willmes et al. · Nature Cell Biology Open access	27 Mar 2011	527
18	Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes ROBERT J. CHILTON, Ilkka Tikkanen, Christopher Paul Cannon et al. · Diabetes Obesity and Metabolism Open access	7 Sep 2015	518
19	Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes Anubha Mahajan et al. · Nature Genetics Open access240 authors	Apr 2018	473
20	Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension Ilkka T. Tikkanen, Kirsi Narko, Cordula Zeller et al. · Diabetes Care	30 Sep 2014	471
21	PLASMA ATRIAL NATRIURETIC PEPTIDE IN CARDIAC DISEASE AND DURING INFUSION IN HEALTHY VOLUNTEERS Ilkka T. Tikkanen, Kaj Peter Metsarinne, Frej Fyhrquist et al. · The Lancet	Jul 1985	469
22	Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease Panu K. Luukkonen, You Zhou, Sanja Sädevirta et al. · Journal of Hepatology Open access	11 Jan 2016	463
23	Liver Fat in the Metabolic Syndrome Anna Kotronen, Jukka Westerbacka, Robert Bergholm et al. · The Journal of Clinical Endocrinology & Metabolism	27 Jun 2007	459
24	Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars Panu K. Luukkonen et al. · Diabetes Care Open access	29 May 2018	439
25	Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci Kyle J. Gaulton et al. · Nature Genetics Open access218 authors	9 Nov 2015	426
26	The impact of low-frequency and rare variants on lipid levels Ida L. Surakka et al. · Nature Genetics Open access	11 May 2015	411
27	Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling Ching Jian, Panu K. Luukkonen, Hannele Yki‐Järvinen et al. · PLoS ONE Open access	15 Jan 2020	398
28	The roles of senescence and telomere shortening in cardiovascular disease Frej Fyhrquist, Outi J. Saijonmaa, Timo E. Strandberg · Nature Reviews Cardiology Review	12 Mar 2013	380
29	Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment Norbert Stefan, Hannele Yki‐Järvinen, Brent A. Neuschwander‐Tetri · The Lancet Diabetes & Endocrinology Open access	13 Dec 2024	378
30	Genes Involved in Fatty Acid Partitioning and Binding, Lipolysis, Monocyte/Macrophage Recruitment, and Inflammation Are Overexpressed in the Human Fatty Liver of Insulin-Resistant Subjects Jukka Westerbacka, Maria Kolak, Tuula A. Kiviluoto et al. · Diabetes Open access	18 Aug 2007	358
31	Genome-wide physical activity interactions in adiposity ― A meta-analysis of 200,452 adults Mariaelisa Graff et al. · PLoS Genetics ReviewOpen access281 authors	27 Apr 2017	345
32	Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls Broad Genomics Platform et al. · Nature Open access173 authors	22 May 2019	343
33	Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose Tissue Insulin Resistance in Type 2 Diabetes Anna Kotronen, Leena Juurinen, Mirja Tiikkainen et al. · Gastroenterology Open access	25 Mar 2008	341
34	Seipin regulates ER–lipid droplet contacts and cargo delivery Veijo T. Salo, Ilya N Belevich, Shiqian Li et al. · The EMBO Journal Open access	22 Nov 2016	337
35	Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity Maria Kolak, Jukka Westerbacka, Vidya Velagapudi et al. · Diabetes Open access	27 Jul 2007	319
36	Endoplasmic Reticulum Stress Inhibition Protects against Excitotoxic Neuronal Injury in the Rat Brain Anna-Leena Sokka, Noora Putkonen, Giuseppa Mudò et al. · Journal of Neuroscience Open access	24 Jan 2007	317
37	HÆMOPHILIA A IN A GIRL Albert de la Chapelle, Esko Ikkala, H. R. Nevanlinna · The Lancet	Sep 1961	308
38	Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease Giuseppa Mudò, Johanna Mäkelä, Valentina Di Liberto et al. · Cellular and Molecular Life Sciences Open access	7 Oct 2011	303
39	Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats Eeva Palojoki, Antti Saraste, Anders Eriksson et al. · American Journal of Physiology-Heart and Circulatory Physiology	Jun 2001	300
40	Aster Proteins Facilitate Nonvesicular Plasma Membrane to ER Cholesterol Transport in Mammalian Cells Jaspreet S. Sandhu et al. · Cell Open access	13 Sep 2018	298
41	Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease Partho Sen, Sami U. Qadri, Panu K. Luukkonen et al. · Journal of Hepatology Open access	8 Oct 2021	295
42	Exercise, smoking, and calcium intake during adolescence and early adulthood as determinants of peak bone mass Matti J. Välimäki, M Kärkkäinen, Christel J. E. Lamberg-Allardt et al. · BMJ Open access	23 Jul 1994	295
43	Losartan in Heart Failure Ian Crozier, Hamid Ikram, Najam A. Awan et al. · Circulation	Feb 1995	292
44	A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans Anna Kotronen, Lovisa E. Johansson, Lina Johansson et al. · Diabetologia Open access	17 Feb 2009	291
45	Dietary carbohydrates and fats in nonalcoholic fatty liver disease Hannele Yki‐Järvinen, Panu K. Luukkonen, Leanne Hodson et al. · Nature Reviews Gastroenterology & Hepatology ReviewOpen access	13 Jul 2021	289
46	Metabolic dysfunction-associated steatotic liver disease in adults Daniel Q. Huang, Vincent Wai‐Sun Wong, Mary Eugenia Rinella et al. · Nature Reviews Disease Primers Review	6 Mar 2025	282
47	Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression Gehao Liang, Yun Ling, Maryam Mehrpour et al. · Molecular Cancer Open access	25 Mar 2020	278
48	New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2) Hannele Yki‐Järvinen, Richard M. Bergenstal, Monika Ziemen et al. · Diabetes Care	6 Sep 2014	276
49	ONTOGENESIS OF THE NUCLEAR 3,5,3′-TRIIODOTHYRONINE RECEPTOR IN THE HUMAN FETAL BRAIN Juan Bernal, Fredrika Pekonen · Endocrinology	Feb 1984	276
50	Effects of Oral and Transdermal Estrogen Replacement Therapy on Markers of Coagulation, Fibrinolysis, Inflammation and Serum Lipids and Lipoproteins in Postmenopausal Women Satu Vehkavaara, Angela Maria Vidigal Silveira, Tiina Hakala‐Ala‐Pietilä et al. · Thrombosis and Haemostasis	2001	271

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.